Hypoxia--a key regulatory factor in tumour growth - PubMed (original) (raw)
Review
doi: 10.1038/nrc704.
Affiliations
- PMID: 11902584
- DOI: 10.1038/nrc704
Review
Hypoxia--a key regulatory factor in tumour growth
Adrian L Harris. Nat Rev Cancer. 2002 Jan.
Abstract
Cells undergo a variety of biological responses when placed in hypoxic conditions, including activation of signalling pathways that regulate proliferation, angiogenesis and death. Cancer cells have adapted these pathways, allowing tumours to survive and even grow under hypoxic conditions, and tumour hypoxia is associated with poor prognosis and resistance to radiation therapy. Many elements of the hypoxia-response pathway are therefore good candidates for therapeutic targeting.
Similar articles
- Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis.
Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Collen D, Keshert E. Carmeliet P, et al. Nature. 1998 Jul 30;394(6692):485-90. doi: 10.1038/28867. Nature. 1998. PMID: 9697772 - Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression.
Makino Y, Cao R, Svensson K, Bertilsson G, Asman M, Tanaka H, Cao Y, Berkenstam A, Poellinger L. Makino Y, et al. Nature. 2001 Nov 29;414(6863):550-4. doi: 10.1038/35107085. Nature. 2001. PMID: 11734856 - [Hypoxia and tumors: does HIF-1 transcription factor favor tumor growth or hypoxia?].
Vandenbunder B. Vandenbunder B. Bull Cancer. 1998 Oct;85(10):843-5. Bull Cancer. 1998. PMID: 9835861 Review. French. - [The hypoxia-inducible factor HIF as a new target in cancer research].
L'Allemain G. L'Allemain G. Bull Cancer. 2002 Mar;89(3):257-60. Bull Cancer. 2002. PMID: 11940464 Review. French.
Cited by
- Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence.
Luis G, Godfroid A, Nishiumi S, Cimino J, Blacher S, Maquoi E, Wery C, Collignon A, Longuespée R, Montero-Ruiz L, Dassoul I, Maloujahmoum N, Pottier C, Mazzucchelli G, Depauw E, Bellahcène A, Yoshida M, Noel A, Sounni NE. Luis G, et al. Redox Biol. 2021 Jul;43:102006. doi: 10.1016/j.redox.2021.102006. Epub 2021 May 14. Redox Biol. 2021. PMID: 34030117 Free PMC article. - Metabolic Characteristics of Advanced Biliary Tract Cancer Using 18F-Fluorodeoxyglucose Positron Emission Tomography and Their Clinical Implications.
Cho KM, Oh DY, Kim TY, Lee KH, Han SW, Im SA, Kim TY, Bang YJ. Cho KM, et al. Oncologist. 2015 Aug;20(8):926-33. doi: 10.1634/theoncologist.2014-0356. Epub 2015 Jun 22. Oncologist. 2015. PMID: 26099746 Free PMC article. - The effect of alpha-v integrin inhibition on the malignant characteristics of medulloblastoma.
Thompson EM, Whitney NL, Wu YJ, Neuwelt EA. Thompson EM, et al. J Neurosurg Pediatr. 2013 Jan;11(1):60-7. doi: 10.3171/2012.9.PEDS12268. Epub 2012 Oct 19. J Neurosurg Pediatr. 2013. PMID: 23082872 Free PMC article. - Exosomes Derived from Hypoxic Colorectal Cancer Cells Transfer miR-410-3p to Regulate Tumor Progression.
Hu X, Mu Y, Liu J, Mu X, Gao F, Chen L, Wu H, Wu H, Liu W, Zhao Y. Hu X, et al. J Cancer. 2020 May 25;11(16):4724-4735. doi: 10.7150/jca.33232. eCollection 2020. J Cancer. 2020. PMID: 32626519 Free PMC article. - Hypoxia-Inducible Factor (HIF) as a Target for Novel Therapies in Rheumatoid Arthritis.
Hua S, Dias TH. Hua S, et al. Front Pharmacol. 2016 Jun 27;7:184. doi: 10.3389/fphar.2016.00184. eCollection 2016. Front Pharmacol. 2016. PMID: 27445820 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources